Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Sotera Health Company, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Indivior Pharmaceuticals Inc. May 13, 202698.4%
-
Indivior Pharmaceuticals Inc. May 8, 202599.9%
-
Sotera Health Company May 23, 202492.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 22, 2026 | Sotera Health Company | Grant or award | +14,970 | — | — |
| May 13, 2026 | Indivior Pharmaceuticals Inc. | Grant or award | +10,430 | — | — |
| Jan 26, 2026 | Indivior Pharmaceuticals Inc. | Grant or award | +5,955 | — | — |
| Jan 5, 2026 | Indivior Pharmaceuticals Inc. | Open-market purchase | +1,771 | $35.39 | $62,676 |
| May 22, 2025 | Sotera Health Company | Grant or award | +19,132 | — | — |
| May 24, 2024 | Sotera Health Company | Grant or award | +20,089 | — | — |
| May 26, 2023 | Sotera Health Company | Grant or award | +15,712 | — | — |
Questions about David E. Wheadon
What boards is David E. Wheadon on?
David E. Wheadon sits on the boards of Indivior Pharmaceuticals Inc., Seaport Therapeutics Inc. and Sotera Health Company.
How long has David E. Wheadon served on boards?
Our records show at least 5 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.